Federal health authorities are intensifying their scrutiny of the mind-altering drug ketamine for treating mental health disorders, as its popularity grows without regulatory approval for such use. Efforts to gain FDA approval for hormone therapies as part of gender-affirming treatment are underway, which could maintain patient access to these therapies as states impose restrictions. Meanwhile, a federal judge in Idaho has put a hold on a state law that would ban gender transition care for minors, a move that would have threatened medical professionals with felony convictions if they provided such care. The law was set to take effect in just six days before the judge's intervention.
A federal judge in Idaho temporarily blocked the enforcement of a state law that bans gender transition care for minors and threatens medical professionals with a felony conviction if they provide such care, just six days before it was set to take effect. https://t.co/YucdhWk4rH
JUST IN: Judge puts Idaho ban on transgender medical care for minors on hold https://t.co/Uy4sIhc3Lg
BREAKING: Judge puts Idaho ban on transgender medical care for minors on hold https://t.co/IxTRH1vcQz
Federal health authorities are intensifying their scrutiny of the drug ketamine for treating mental health disorders, as the mind-altering compound grows in popularity despite the lack of regulatory approval for such use. https://t.co/S5ZgzD3IDt
An effort to get the FDA's approval of hormone therapies for gender-affirming treatment could help preserve patients' access to the therapies as states restrict them. https://t.co/tXIUAn4MPC